Authors

• Marleen van Wely (ORCID: https://orcid.org/0000-0003-4579-111X)
• Ahmed Elkoumy (ORCID: https://orcid.org/0000-0002-6325-1056)
• Tsung‐Ying Tsai (ORCID: https://orcid.org/0000-0002-0426-9360)
• Robin H. Heijmen (ORCID: https://orcid.org/0000-0003-1503-2374)
• Niels van Royen (ORCID: https://orcid.org/0000-0001-6136-8640)
• Maxim J P Rooijakkers (ORCID: https://orcid.org/0000-0002-6815-7667)
• Patrick W. Serruys (ORCID: https://orcid.org/0000-0002-9636-1104)
• Niels A. Stens (ORCID: https://orcid.org/0000-0001-7487-151X)
• Geert A. A. Versteeg (ORCID: https://orcid.org/0009-0002-1583-2953)
• Laura Rodwell (ORCID: https://orcid.org/0000-0002-5635-4997)
• Osama I.I. Soliman (ORCID: https://orcid.org/0000-0003-0758-3539)

Institutions

• Radboud University Nijmegen (NL)
• Al-Azhar University (EG)
• Radboud University Medical Center (NL)

Publication Details

Journal

Journal of the American Heart Association

Published

2024-09-13

DOI

https://doi.org/10.1161/jaha.124.035587

Citations

2

Primary Topic

Cardiac Valve Diseases and Treatments

Type

article

Field-Weighted Citation Impact

0.80

Funders

• Abbott Laboratories